Stratton K, Howe C, Battaglia F (1996) Fetal alcohol syndrome: Diagnosis, epidemiology, prevention, and treatment. Washington (D. C.): National Academy Press. 213 p.
[2]
Sampson PD, Streissguth AP, Bookstein GL, Little RE, Clarren SK, et al. (1997) Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorder. Teratology 56: 317–326.
Zhou FC, Sari Y, Powrozek TA, Spong CY (2004) A neuroprotective peptide antagonizes fetal alcohol exposure compromised brain growth. J Mol Neurosci 24: 189–199.
[6]
Endres M, Toso L, Roberson R, Park J, Abebe D, et al. (2005) Prevention of alcohol-induced developmental delays and learning abnormalities in a model of fetal alcohol syndrome. Am J Obstet Gynecol 193: 1028–1034.
[7]
Spong CY, Abebe DT, Gozes I, Brenneman DE, Hill JM (2001) Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome. J Pharmacol Exp Ther 297: 774–779.
[8]
Kilburn BA, Chiang PJ, Wang J, Flentke GR, Smith SM, et al. (2006) Rapid induction of apoptosis in gastrulating mouse embryos by ethanol and its prevention by HB-EGF. Alcohol Clin Exp Res 30: 127–134.
[9]
Heaton MB, Madorsky I, Paiva M, Siler-Marsiglio KI (2004) Vitamin E amelioration of ethanol neurotoxicity involved modulation of apoptosis-related protein levels in neonatal rat cerebellar granule cells. Brain Res Dev 150: 117–124.
[10]
Ieraci A, Herrera DG (2006) Nicotinamide protects against ethanol-induced apoptotic neurodegeneration in the developing mouse brain. PLoS Med 3: e101. doi: 10.1371/journal.pmed.0030101.
